5-chloro-4-(2-imidazolin-2-yl-amino)-2,1,3-benzothiadiazole,
DS 103-282,
Sirdalud,
tizanidine,
tizanidine hydrochloride,
tizanidine monohydrochloride,
Zanaflex,
Tizanidine hydrochloride,
Tizanidine Hcl,
64461-82-1,
Zanaflex,
Sirdalud,
5-Chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-2,1,3-benzothiadiazol-4-amine hydrochloride,
Tizanidine (hydrochloride),
UNII-B53E3NMY5C,
DS 103-282,
B53E3NMY5C,
MFCD00798231,
5-Chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-2,1,3-benzothiadiazole-4-amine hydrochloride,
DS-103-282,
5-Chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole hydrochloride,
5-Chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole monohydrochloride,
5-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)benzo[c][1,2,5]thiadiazol-4-amine hydrochloride,
5-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-2,1,3-benzothiadiazol-4-amine;hydrochloride,
2,1,3-Benzothiadiazol-4-amine, 5-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-, monohydrochloride,
CPD000499584,
SMR000499584,
AN-021,
SR-01000765392,
Zanaflex;Sirdalud,
Zanaflex (TN),
Tizanidine hydrochloride [USAN:JAN],
Tizanidine-hydrochloride,
Tizanidine hydrochloride [USAN:USP:JAN],
C9H8ClN5S.HCl,
tizanidine monohydrochloride,
C9H9Cl2N5S,
AC1Q3B8M,
AC1Q3BC5,
SCHEMBL41199,
MLS001076686,
MLS001306412,
MLS001333593,
ARONIS24403,
AC1L3G42,
CHEBI:9609,
CHEMBL1200329,
DTXSID9046990,
DS-103282 ch,
HY-B0194A,
AN-021A,
NVD-422,
ZWUKMNZJRDGCTQ-UHFFFAOYSA-N,
AN021,
BCP28540,
Tox21_501114,
AB-021,
s1437,
SBB080814,
AKOS005267234,
BRN0618691,
CCG-220602,
CCG-222418,
CS-2091,
KS-1120,
LP01114,
NC00654,
NE33269,
Tizanidine hydrochloride (JP17/USAN),
5-chlor-n-(4,5-dihydro-1h-imidazol-2-yl)-2,1,3-benzothiadiazol-4-aminhydrochlorid,
KS-0000478D,
NCGC00261799-01,
AC-22546,
AN-38752,
LS-40461,
M962,
SAM002548961,
SAM002643509,
SC-12218,
AB0015475,
AB2000107,
DB-051946,
DS-103282,
AK00022647,
FT-0656022,
SW199068-2,
EN300-49853,
D00776,
A828535,
Tizanidine hydrochloride, >=98% (HPLC), powder,
I14-2831,
SR-01000765392-4,
5-chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazolehydrochloride,
5-chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiodiazole hydrochloride,
Tizanidine hydrochloride, European Pharmacopoeia (EP) Reference Standard,
(5-chlorobenzo[2,3-c]1,2,5-thiadiazol-4-yl)-2-imidazolin-2-ylamine, chloride,
5-(Chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-2,1,3-benzothiadiazol-4-amine hydrochloride,
5-chloranyl-N-(4,5-dihydro-1H-imidazol-2-yl)-2,1,3-benzothiadiazol-4-amine hydrochloride,
5-Chloro-4-[(4,5-dihydro-1H-imidazol-2-yl)amino]-2,1,3-benzothiadiazole Hydrochloride,
5-Chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-2,1,3benzothiadiazole-4-amine hydrochloride,
Tizanidine hydrochloride, 500 mug/mL in methanol, certified reference material,
Tizanidine hydrochloride, United States Pharmacopeia (USP) Reference Standard,
2,1,3-benzothiadiazol-4-amine,5-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-, monohydrochloride,
tizanidine,
Ternelin,
Tizanidina clorhidrato,
Tizanidinehydrochloride,
C9H8ClN5S.ClH,
C9-H8-Cl-N5-S.Cl-H,
AR-1G7639,
CID114869,
CS-O-11759,
51322-75-9,
B1368,
T2527,
2,1,3-Benzothiadiazol-4-amine, 5-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-,
2,1,3-Benzothiadiazol-4-amina, 5-cloro-N-(4,5-dihidro-1H-imidazol-2-il)-, monoclorhidrato (9CI),
2,1,3-Benzotiadiazol-4-amina, 5-cloro-N-(4,5-dihidro-1H-imidazol-2-il)-,clorhidrato(1:1),
6628-40-6,